| |
You're In Charge.
At LabTest MD you request your
choice of laboratory tests from the
list on the left. You can choose any
of our physician designed panels
or look over our most popular 62
individual tests. If you don't see what you're looking for, we have over 1,000 other tests - just give us a call for pricing.
Tests results are confidential and given only to you, the patient. Results are typically available for pickup within 24-72 hours at any of our five Atlanta locations or can be mailed, faxed or securely emailed using our .mdEmail® encryption service.
Why Use LabTest MD?
Confidential and Convenient!
We see customers everyday
face to face and understand
exactly what you're looking for.
If you're in the Atlanta area
please stop by any of our five convenient clinic locations.
clinics you can use any LabCorp draw station in the state of
Need Help?
Our customer service specialists are just a phone call away.
And while our website lists the most popular tests requested
by consumers, we have over 1,000 tests available. If you have
any questions or you don't see the test you are looking for,
please call us at 1-877-720-0777.
Payment Terms:
All tests must be paid for at the time of order with Cash, Check,
American Express, Visa, Discover, MasterCard or PayPal. If you
come to one of our clinics, you can pay at our clinic. If you use
a LabCorp location, you'll have to pay online. We do not file
insurance claims or send bills for our testing services. All credit
card charges will appear on your statement as “LTMD”.
|
 |
Test of the Month. |
|
|
|
Simple STD Panel
|
List Price: $183.00
Our Price: $109.00
You Save $74.00
|
|
|
Tests included in our panel:
-HSV Type 2-Specific Ab, IgG
-HIV 1/0/2 Antibodies
-Syphilis
STD Panel
|
|
|
|
 |
Article of the Month
"Breast Cancer Awareness Month "
Obesity, Drinking, Smoking Contribute To Risk Of Second Breast Cancers
Obesity, smoking and alcohol use increase the risk that survivors of estrogen receptor-positive breast cancer will develop the disease in the other breast, according to a study published this week in the Journal of Clinical Oncology, Reuters reports. The study examined data on 365 women with a first estrogen receptor-positive breast cancer and a second cancer in the other breast, and 726 similar subjects without the second cancer.
Read more...
|
